Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/27/2003CA2752140A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-1-yl)-piperidine-2,6-dione for treatment and management of renal cancer
11/27/2003CA2752127A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of hepatocellular carcinoma
11/27/2003CA2752124A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of head and neck cancer
11/27/2003CA2752122A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of ovarian cancer
11/27/2003CA2727830A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
11/27/2003CA2727824A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of solid tumors
11/27/2003CA2525672A1 Use of peroxovanadium compounds as tumour cell growth suppressor
11/27/2003CA2511604A1 Treatment of cancer by the use of anti fas antibody
11/27/2003CA2497601A1 Pyrroloquinoline quinone for treatment of cardiac injury and methods of use thereof
11/27/2003CA2489102A1 Use of quinoline derivatives with anti-integrase effect and applications thereof
11/27/2003CA2487247A1 Drug therapy for celiac sprue
11/27/2003CA2486881A1 Process for the preparation and activation of substances and a means of producing same
11/27/2003CA2486635A1 Drug delivery assembly
11/27/2003CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor
11/27/2003CA2486465A1 Amidoacetonitrile compounds
11/27/2003CA2486327A1 Htlv-i tax induced killing of p53 null cancer cells
11/27/2003CA2486302A1 Methods for the prevention and/or the treatment of neurological disorders
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003CA2486138A1 Methods of using thiazolidinedithione derivatives
11/27/2003CA2486127A1 Method of treating dyslipidemic disorders
11/27/2003CA2486124A1 Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
11/27/2003CA2486121A1 Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction
11/27/2003CA2486106A1 Compounds and methods for inhibiting selectin-mediated function
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2486061A1 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003CA2486000A1 Use of compounds that are effective as selective opiate receptor modulators
11/27/2003CA2485989A1 Methods and compositions for the treatment of ischemic reperfusion
11/27/2003CA2485966A1 Novel substituted sulfamate anticonvulsant derivatives
11/27/2003CA2485933A1 5-ethylimidarotriazones
11/27/2003CA2485896A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors
11/27/2003CA2485869A1 Oral therapeutic or preventive drugs for pollakiuria and urinary incontinence or oral sleep inducers, containing tropolone derivatives
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2485736A1 Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2485589A1 Small molecule inhibitors of her2 expression
11/27/2003CA2485586A1 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003CA2485502A1 An antimicrobial agent
11/27/2003CA2485466A1 Treatment of neuropathic pain
11/27/2003CA2485463A1 A direct cellular energy delivery system
11/27/2003CA2485367A1 Diaminothiazoles
11/27/2003CA2485214A1 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2485212A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/27/2003CA2485081A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003CA2485012A1 1h-imidazo[4,5-c] quinoline derivatives in the treatment of protein kinase dependent diseases
11/27/2003CA2485006A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003CA2484989A1 Methods and compositions for treating t cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency
11/27/2003CA2484702A1 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003CA2484671A1 Cyanoguanidine prodrugs
11/27/2003CA2484654A1 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003CA2484646A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003CA2484512A1 Treatment of cataracts and other ophthalmic diseases
11/27/2003CA2484324A1 Methods using a combination of a 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/27/2003CA2484308A1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003CA2484238A1 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer
11/27/2003CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
11/27/2003CA2484011A1 Cysteine protease inhibitors
11/27/2003CA2483770A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003CA2483634A1 Reduction of hair growth
11/27/2003CA2483619A1 Novel compounds and their use
11/27/2003CA2483600A1 Polymorphic forms of phenyl oxazolidinone derivatives
11/27/2003CA2483591A1 Lactams used as anti-viral agents
11/27/2003CA2483368A1 (s)-4-amino-5-chloro-2-methoxy-n-¬1-¬1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl|-4-piperidinyl|benzamide, process for the preparation thefeof, pharmaceutical composition containing the same, and intermediate therefor
11/27/2003CA2483286A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/27/2003CA2483190A1 External preparation for allergic diseases
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/27/2003CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003CA2482458A1 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
11/27/2003CA2482348A1 Combinations of an ace inhibitor, a calcium channel blocker and a diuretic
11/26/2003EP1365246A1 Diagnostics and therapeutics for diseases associated with neuromedin U2 receptor (NMU2)
11/26/2003EP1365034A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/26/2003EP1364959A1 Crystal of pyrimidine nucleoside derivative
11/26/2003EP1364954A1 Dicarba-closo-dodecarborane derivatives
11/26/2003EP1364950A1 Pyridopyrimidine or naphthyridine derivative
11/26/2003EP1364944A1 Frangible Compounds for Pathogen Inactivation
11/26/2003EP1364943A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors
11/26/2003EP1364659A1 Remedies for urinary diseases comprising lpa receptor controlling agents
11/26/2003EP1364655A1 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma
11/26/2003EP1364653A1 Casoase 3 inhibitors
11/26/2003EP1364652A1 Remedies for lung cancer
11/26/2003EP1364650A1 Medicinal composition
11/26/2003EP1364649A1 Adduct of topiramate and tramadol hydrochioride and uses thereof
11/26/2003EP1364648A1 Cryptotanshinone for preventing and alleviating alzheimer's disease
11/26/2003EP1364647A1 Hypoglycemic agent
11/26/2003EP1364646A1 Fenofibrate-containing composition
11/26/2003EP1364645A1 Pharmaceutical combinations for topical use based on iron chelators, metalloprotease inhibitors and factor XIII for the treatment of lipodermatosclerosis and trophic lesions of the cutaneous tissues and muccous membranes
11/26/2003EP1364644A1 Pharmaceutical formulation with extended release
11/26/2003EP1364643A1 Composition improved in solubility or oral absorbability
11/26/2003EP1364642A1 Composition for delivery of dithranol
11/26/2003EP1364641A1 Use of at least one metal complex as a desquamative agent
11/26/2003EP1364628A1 Coated medical devices
11/26/2003EP1364054A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
11/26/2003EP1364053A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/26/2003EP1364044A2 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363951A2 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
1 ... 5263 5264 5265 5266 5267 5268 5269 5270 5271 5272 5273 5274 5275 5276 5277 5278 5279 5280 5281 5282 5283 ... 7860